Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Eureka Genomics Lands a NIFA Award for $100,000

Published: Thursday, June 28, 2012
Last Updated: Thursday, June 28, 2012
Bookmark and Share
Development of bovine parentage genotyping by highly multiplex next generation sequencing.

The National Institute of Food and Agriculture (NIFA), USDA issued a $100,000 award for the development of Bovine Parentage Genotyping by Highly Multiplex Next Generation Sequencing.

This project is related to a Cooperative Research and Development Agreement (CRADA) between Eureka Genomics and the Agricultural Research Service, USDA to develop a low cost, low-density marker assay (LDMA) focused on the bovine industry.

The core technology for low cost high-throughput genotyping will have applications across animal, plant and clinical markets.

"The collaboration has resulted in a very cost-effective, high-throughput approach to single nucleotide polymorphism (SNP) genotyping, which is currently available for bovine parentage testing as well as for custom applications. Continuing development efforts are focused on increasing the number of SNPs that can be included in an assay, on further reducing the costs of adding SNP to assays, and on expanding the approach to include additional types of polymorphisms," said Mark Thallman, Ph.D. Research Geneticist and co-inventor of the technology, at the U.S. Meat Animal Research Center.

"The success of and knowledge created during the collaboration between Eureka Genomics and the USDA on LDMA for high-throughput genotyping is being leveraged into an ongoing collaboration between Eureka Genomics and the USDA that has expanded to include many diverse areas including 16S characterization and improved sample handling for next generation sequencing. Eureka Genomics is very pleased to continue to work with the U.S. Meat Animal Research Center to improve the applications of high throughput sequence data in the agricultural setting," said Heather Koshinsky, PhD., CSO, Eureka Genomics.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Honey’s Potential to Save Lives
The healing powers of honey have been known for thousands of years.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Cytoskeleton Crew
Findings confirm sugar's role in helping cancers survive by changing cellular architecture.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!